"Palm Vascular Centers specializes in the care of vascular disease using innovative approaches that rely on safe and effective minimally invasive techniques. We offer the latest treatments for peripheral arterial disease (PAD) and comprehensive dialysis access procedures and care, as well as a range of other medical services. Our state-of-the-art outpatient facilities offer both the latest technology for vascular care and a safe, comfortable, and private environment for our patients. Our highly skilled and experienced interventional radiologists, interventional cardiologists, and our supporting medical staff provide the highest level of care to our patients."

During the past decade, Palm Vascular Centers conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palm Vascular Centers" #1 sponsor was "Abbott Medical Devices" with 1 trials, followed by "AngioSafe, Inc." with 1 trials sponsored, "Merit Medical Systems, Inc." with 1 trials sponsored, "Midwest Cardiovascular Research Foundation" with 1 trials sponsored and "PQ Bypass, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palm Vascular Centers" #1 collaborator was "Angiodynamics, Inc." with 1 trials as a collaborator, "Syntactx" with 1 trials as a collaborator and "Veranex, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Palm Vascular Centers" are "Peripheral Arterial Disease" (4 trials), "Chronic Venous Insufficiency" (1 trials), "Critical Limb Ischemia (CLI)" (1 trials), "Deep Vein Thrombosis" (1 trials) and "May-Thurner Syndrome" (1 trials). Many other conditions were trialed in "Palm Vascular Centers" in a lesser frequency.

Most popular intervention types in "Palm Vascular Centers" are "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "AngioSafe Peripheral CTO Crossing System" (1 trials), "Auryon Laser System" (1 trials), "BioMimics 3D Vascular Stent System" (1 trials), "Duo Venous Stent System" (1 trials) and "Esprit BTK Device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Palm Vascular Centers" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Palm Vascular Centers". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Palm Vascular Centers, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Palm Vascular Centers, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".